Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Steven Kanner | Chief Scientific Officer | 2024-02-06 | 30,577 | $2.69 | $82.25kBuy |
Rachel E. Haurwitz | President and CEO | 2023-06-08 | 10,000 | $2.96 | $29.60kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Blackrock Inc | 7.83% | 7,068,468 | $28.34M | Institution |
Pfm Health Sciences LP | 7.18% | 6,480,764 | $25.99M | Institution |
Avidity Partners Management LP | 7.04% | 6,360,212 | $25.50M | Institution |
State Street Corp | 5.67% | 5,119,666 | $20.53M | Institution |
Vanguard Group Inc | 4.39% | 3,962,044 | $15.89M | Institution |
Point72 Asset Management LP | 3.90% | 3,521,376 | $14.12M | Institution |
Rachel E. Haurwitz | 3.88% | 3,508,095 | $14.07M | Insider |
Fmr LLC | 3.68% | 3,323,284 | $13.33M | Insider |
Alkeon Capital Management LLC | 3.45% | 3,113,564 | $12.49M | Institution |
Paradigm Biocapital Advisors LP | 3.24% | 2,923,851 | $11.72M | Institution |